Track DNLI and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
DNLI - Denali Therapeutics Inc (DNLI) has a earnings per share of -$0.69, up 11.5% over the past year.
Latest EPS (Actual)
-$0.69
Beat Rate
25.0%
Most Recent
Meet
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.71 | -$0.69 | Meet | +2.82% |
| Feb 2026 | -$0.75 | -$0.73 | Meet | +2.67% |
| Nov 2025 | -$0.76 | -$0.74 | Meet | +2.63% |
| Aug 2025 | -$0.74 | -$0.72 | Meet | +2.70% |
| May 2025 | -$0.70 | -$0.78 | Miss | -11.43% |
| Feb 2025 | -$0.85 | -$0.67 | Beat | +20.79% |
| Nov 2024 | -$0.63 | -$0.63 | Meet | +0.00% |
| Aug 2024 | -$0.69 | -$0.59 | Beat | +14.49% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.